STAAR Surgical logo
STAAR Surgical
STAA | NASDAQ
Chart Builder DCF Calculator
$26.01
-$0.38 (-1.44%)
At close: Nov 16, 2026, 4:00 PM ET
$26.01
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

STAAR Surgical Company Profile

Company profile explained

Company Profile

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.

Key Executives

Name Position
Warren Foust CEO, President & Director
Ben Park Chief Technology Officer
Connie Johnson Director of Investor Relations
David Bailey Chief Commercial Officer
Deborah J. Andrews Executive VP & CFO
Filip De Keersmaecker Chief Supply Chain & Quality Officer
Kathleen Determann VP, Deputy General Counsel and Chief Compliance & Privacy Officer
Magda Michna Chief Development Officer
Scott D. Barnes Chief Medical Officer
William W. Goodmen Vice President of Global Human Resources

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 05, 2026 8-K/A [Amend] Current Report
Sep 10, 2026 8-K Current Report
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 10-Q Quarterly Report
Aug 12, 2026 8-K Current Report
Aug 06, 2026 8-K Current Report
View All SEC Filings ➞
STAAR Surgical
STAAR Surgical logo
Country United States
IPO Date Feb 24, 1992
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 921
CEO Warren Foust

Contact Details

25510 Commercentre Drive Lake Forest, California 92630 United States

Stock Details

Ticker Symbol STAA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000718937
CUSIP Number 852312305
ISIN Number US8523123052
SIC Code 3851

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.